As of 2025-03-16, the Relative Valuation of Landos Biopharma Inc (LABP) is (136.06) USD. This relative valuation is based on P/E multiples. With the latest stock price at 22.93 USD, the upside of Landos Biopharma Inc based on Relative Valuation is -693.4%.
The range of the Relative Valuation is (127.70) - (156.22) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.2x - 19.7x | 16.1x |
| Forward P/E multiples | 16.1x - 20.9x | 18.2x |
| Fair Price | (127.70) - (156.22) | (136.06) |
| Upside | -656.9% - -781.3% | -693.4% |
| Date | P/E |